Do Newer Implant Brands Really Have Lower Contracture Rates?

I had a few questions in my DMs over the weekend about capsular contracture rates with different implant brands, so let's talk about how to actually read those numbers. Because the marketing is doing a lot of work here.

Here's the pattern. Some of the newer implant brands advertise a capsular contracture rate that is very low. Impressive on its face.

But look at what they're comparing it to: old data from two of the older brands, from when those implants first came back on the market in the early 2000s.

That comparison is the problem.

We have learned an enormous amount about what causes capsular contracture and what minimizes it over the last 20 years.

Which means a lot of those older studies were conducted in an era when things were routinely done in ways that increase your rate of contracture. Not because anyone was careless, but because the field hadn't learned yet.

When a modern product is measured against a two-decade-old baseline, you are largely measuring twenty years of surgical progress and attributing it to the shell.

This is the heart of it. We now know specific things about implant placement that drive contracture risk, and many of them either weren't done in the older studies or weren't controlled for the way current studies control for them:

• Where is the incision placed? Certain incisions carry a higher risk of contracture than others.
• Was a Keller funnel used? A sterile funnel lets the implant go in without being handled or touching skin.
• What irrigation was used? Antibacterial irrigant solutions meaningfully reduce contamination of the pocket.
• Was the nipple-areolar complex covered? Shielding the NAC limits exposure to bacteria from the ducts.

Every one of those is a technique variable, not a product variable. Run an old implant with modern technique and the numbers look very different. That's exactly the toolkit I walk through in how surgeons actually prevent implant infection and biofilm in the OR.

Here's the fact that deflates the whole pitch:

Contracture rates with the more established brands are low in recent studies as well.

When you compare modern data to modern data, rather than modern data to early-2000s data, the dramatic brand gap largely disappears. Rates across the board have fallen from the 10 to 15% seen in older approval studies to under 2% in contemporary series.

So the honest read isn't "this new implant solved contracture." It's "we all got much better at this," and every brand benefits.

Don't let the marketing fool you.

When you're evaluating any claim about contracture rates, ask what the number is being compared against:

• Is it modern data vs. modern data, or modern vs. a 20-year-old baseline?
• Were incision choice, funnel use, irrigation, and NAC coverage standardized between the groups?
• Is the claim coming from a manufacturer with a product to sell?

And most importantly, remember where your actual risk is determined:

That's a genuinely useful reframe when you're choosing. The surgeon's technique is doing more work than the brand is.

• Newer brands advertise very low contracture rates, but often benchmark them against early-2000s data from older brands.
• That comparison spans 20 years of technique improvement, so the difference can't be attributed to the implant.
• Older studies didn't control for incision location, Keller funnel use, irrigation, or NAC coverage, all of which change contracture risk.
• Established brands show low rates in recent studies too. Compare modern data to modern data.
• Rates have fallen from roughly 10 to 15% historically to under 2% today, across the field.

When you're having any implant surgery, the technique matters at least as much as the brand. Ask your surgeon what they do to minimize contracture, the answer will tell you far more than a manufacturer's brochure.